FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring
- PMID: 33892622
- PMCID: PMC8066957
- DOI: 10.1186/s11689-021-09358-1
FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring
Abstract
FOXP1 syndrome is a neurodevelopmental disorder caused by mutations or deletions that disrupt the forkhead box protein 1 (FOXP1) gene, which encodes a transcription factor important for the early development of many organ systems, including the brain. Numerous clinical studies have elucidated the role of FOXP1 in neurodevelopment and have characterized a phenotype. FOXP1 syndrome is associated with intellectual disability, language deficits, autism spectrum disorder, hypotonia, and congenital anomalies, including mild dysmorphic features, and brain, cardiac, and urogenital abnormalities. Here, we present a review of human studies summarizing the clinical features of individuals with FOXP1 syndrome and enlist a multidisciplinary group of clinicians (pediatrics, genetics, psychiatry, neurology, cardiology, endocrinology, nephrology, and psychology) to provide recommendations for the assessment of FOXP1 syndrome.
Keywords: ASD; Autism spectrum disorder; FOXP1; FOXP1 syndrome; Forkhead box protein 1.
Conflict of interest statement
AK receives research support from AMO Pharma and consults to Ovid Therapeutics, Acadia, Ritrova, and Alkermes. The authors declare no competing interests.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
